JOHN LEE: Open Payments
NPI 1104813427 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,464 in 89 payments from 13 companies in 2025. Trend: 2023 $1,889 · 2024 $1,463 · 2025 $1,464
Food & beverage: $1,462Education: $1
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 9 | $195 |
| Alkermes, Inc. | 8 | $183 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $181 |
| ABBVIE INC. | 14 | $180 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $172 |
| Collegium Pharmaceutical, Inc. | 8 | $162 |
| Otsuka America Pharmaceutical, Inc. | 8 | $139 |
| Supernus Pharmaceuticals, Inc. | 4 | $97 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
| Corium, LLC | 2 | $43 |
Products named: REXULTI, ARISTADA, CAPLYTA, VRAYLAR, TRINTELLIX, Jornay PM, Qelbree, COBENFY.
Industry payments across VA — which companies pay providers there.
